ctrl K

Watchlist Price Alert

Apimeds Pharmaceuticals U... (APUS)

NYSE: APUS · Real-Time Price · USD

1.83

0.05 (2.81%)

At close: Jun 20, 2025, 3:39 PM

1.90

3.90%

Pre-market: Jun 23, 2025, 08:00 AM EDT

Apimeds Pharmaceuticals US Inc Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a
Operating Income	-1.28M	-747.44K	-639.53K	-1.02M
Interest Income	2.82K	7.81K	n/a	n/a
Pretax Income	-1.39M	-777.69K	-668.67K	-1.03M
Net Income	-1.39M	-777.69K	-668.67K	-1.03M
Selling & General & Admin	1.28M	648.89K	271.53K	529.55K
Research & Development	n/a	98.54K	368K	489.94K
Other Expenses	n/a	n/a	n/a	n/a
Operating Expenses	1.28M	747.44K	639.53K	1.02M
Interest Expense	117.72K	38.07K	29.14K	6.74K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a
Cost & Expenses	1.28M	747.44K	639.53K	1.02M
Income Tax Expense	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	11.53M	11.53M	11.53M	11.53M
Shares Outstanding (Diluted)	12.69M	12.69M	12.69M	12.69M
EPS (Basic)	-0.12	-0.07	-0.06	-0.09
EPS (Diluted)	-0.11	-0.06	-0.05	-0.08
EBITDA	-1.27M	-739.63K	-639.53K	-1.02M
EBIT	-1.27M	-739.63K	-639.53K	-1.02M
Depreciation & Amortization	n/a	n/a	n/a	n/a